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Highlights 
 
 A Hepatitis A outbreak among young adult MSM occurred in 2017-2018 
in Argentina.  
 HAV genotype IA, strain VRD 521–2016, was the responsible of the 
outbreak. 
 Reinforce official policy of vaccination in MSM is mandatory.  
 
 
1.Background 
Infection with Hepatitis A virus (HAV) is the most common cause of acute viral 
hepatitis worldwide [1]. 
In the past, Argentina was considered to be an area of high endemicity for HAV 
infection, with most people infected in early childhood [2]. Then, HAV was the 
main cause of liver transplant, with 70.5 to 173.8 reported cases of hepatitis 
every 100,000 inhabitants per year during 1995–2004 [3]. Nowadays, HAV has 
shown intermediate endemicity and notification of clinical cases has decreased 
drastically since the introduction of the vaccine among children of 12 months, in 
2005 [4]. Subsequent studies have demonstrated high persistence of protective 
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antibodies up to 4 and 7 years after immunization [5,6]. However, as a 
consequence of the implementation of immunization in children, and the 
improvement in socio-economic, hygienic and sanitation factors, young adults 
are becoming increasingly susceptible to HAV infections [7]. 
The most common vehicles for HAV transmission are: the ingestion of 
contaminated water and contact with infected people. Sexual transmission, 
especially in men who have sex with men (MSM), has also been reported [8,9]. 
During June-2016 - May-2017, several outbreaks of hepatitis A (HA) were 
recorded in Europe, especially described in MSM [9]. The viruses responsible 
for these outbreaks belonged to genotype IA and grouped with one of these 
three strains: VRD_521_2016, RIVM-HAV16-090 and V16-25801. Similarly, in 
the same period, HA outbreaks affecting primarily MSM were reported in North 
America (USA, January-2017, strains: VRD_521_2016 and RIVM-HAV16-090) 
and South America (Chile, November 2016 -October 2017, strain: V16-25801; 
Brazil August 2017 - January 2018, strains: VRD_521_2016 and RIVM-HAV16-
090) [10-12].   
On 30 December 2017, the local public health authority of Cordoba province, 
central region of Argentina, informed an increase in the number of cases of HA, 
primarily among males. Following this information, epidemiological and 
virological surveillance of HA was enhanced. 
We describe an outbreak that disproportionally affected HAV-unvaccinated 
young adult men, primarily MSM, occurred later than Europe. 
 
2. Objective 
 
The purpose of this study was to describe, characterize and contextualize 
epidemiologically the HA outbreak has occurred in Córdoba, central region of 
Argentina, between july2017 and april2018. 
 
3. STUDY DISEGN.  
 
3.1 Case definition 
According to the Argentinean Ministry of Health, the surveillance criteria for 
acute HA cases are: a) suspected clinical case: compatible clinical features with 
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elevated liver enzymes (2.5 folds the reference value of 7-55 U/L); b) confirmed 
case: suspected case plus positive anti-HAV IgM, or a suspected case with 
proven epidemiological link with a confirmed case (cohabiting, contact or having 
been exposed to the same source in the case of an outbreak) [8].  
 
3.2 Enhanced surveillance.  
Due to the increase of HA cases in the notification system of Argentina in 
calendar week 51/2017, we (arbitrarily) considered a possible outbreak 
beginning in the calendar week 29/2017 (starting 30 July), when the first case of 
HA in an adult MSM was recognised (Figure 1). In this context samples of 
serum and / or stool from 32 HA cases were retrospectively studied.  
 
3.3 Samples, Viral extraction and molecular analysis 
Nucleic acid isolation, reverse transcription Nested PCR (RT-Nested PCR) and 
sequencing were conducted as described elsewhere using unified protocols 
published in the HAV-Net, in all samples (serum or stool) of cases with positive 
IgM anti-HAV notified since calendar week 29 [13]. Positive samples were 
sequenced using an automatized sequencer (3500xL Genetic Analyzer - 
Applied Biosystems). Sequences obtained were entered into the HAV-Net 
database, and were used to perform phylogenetic analysis. A rooted maximum 
likelihood phylogenetic consensus tree for sequences of 360 nucleotide (nt) 
long fragments in the VP1/2A junction region was inferred using MEGA version 
6 software [14]. 
 
4. Results 
 
Until 20 April 2018, 32 cases of HA were notified in Cordoba province since July 
2017 (week 29). Of these, 28 were male, and 4 were female (Table 1). The 
main characteristics of these patients are shown in Table 1.  
Sexual orientation was known for 27 cases (23 men, 4 woman); 16 (69.6%) 
identified themselves as MSM and 50% (8/16) of them were infected with 
human immunodeficiency virus (HIV). Median age of the MSM cases was 31.9 
years (range: 21–55 years); all of them lived in Cordoba city (second most 
populated city of Argentina).  In terms of disease severity, among patients for 
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which clinical information was available (n= 23), jaundice occurred in 90% of the 
cases (n= 21) and severe hepatic failure in 26% of them (n=6). Three cases, 
had a travel history outside Argentina to Peru, Chile, and Ecuador, during the 
assumed period of infection. Most of the adults involved in the outbreak were 
unvaccinated, except one MSM who was vaccinated with one dose of a 
monovalent hepatitis A vaccine 15 years before disease onset. Two cases were 
unvaccinated children living in a different geographical area, 86 km away from 
Córdoba city.  
For comparison, in the same period July 2014 – April 2015, July 2015 – April 
2016, and July 2016-April 2017, 3, 7 and 5 cases of HA were reported, 
respectively. Among these, none were identified as MSM.  
All samples of this study were subjected to RT-Nested-PCR, 14 of them had a 
positive result and were sequenced. A good quality sequence could be obtained 
for 11 samples. Phylogenetic analysis of them showed one cluster of MSM-
related HAV strains from Cordoba, Argentina (Figure 2), which grouped with the 
strain VDR521-2016, associated with outbreaks in MSM in Europe between 
June 2016 and May 2017 [9]. Two sequences obtained from patients who were 
not MSM (CbaARGFDAYO Case Nov/2017: Female patient, 6 years old, not 
vaccinated, inhabitant at 86Km from Córdoba city, and CbaARG_15 Case 
March/2018: Female adult patient reporting travel to Ecuador) grouped within 
strain V16-25801 group, together with Chilean MSM-associated sequences 
(Figure 2). 
The sequence CbaARG_25, corresponded to a non-vaccinated male adult, not 
associated with MSM, reported in April 2018, grouped separately from the 
outbreak sequences, with the reference sequence X83202 (from Italy, 1990’s 
decade) and with the strain CbaARG_31_2016, amplified from a case of HA 
occurred at the beginning of 2016. 
 
5. Discussion 
 
Here we report a hepatitis A outbreak among MSM in the central region of 
Argentina, started in mid-2017. All sequences amplified were phylogenetically 
closely related, indicating the circulation of the same strain belonging to 
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genotype IA (VDR- 521-2016) in MSM and suggesting a common source of 
infection.  
Currently, as both sanitary and socioeconomic conditions have been improved 
in some areas of the world, the age of infection has shifted to older groups, and 
thus the number of symptomatic cases has increased. In this sense, in a similar 
way to was happened in other parts of the world, in this study cases occurred in 
patients of average age of around 30 years. 
Previous studies conducted in our region, demonstrated above 40% 
susceptibility to HAV infection, both in healthy adult individuals and in 
immunocompromised HIV infected patients, especially in that age range [7,15]. 
On the other hand, we evidenced the presence of HAV RNA in sewage and 
river samples during the same period in which susceptible individuals were 
found. These findings demonstrate the potential risk of infection for these 
individuals in our area [7,16]. 
Argentina follows the World Health Organization (WHO) recommendations 
about HAV vaccination [17], which includes free HAV risk-based vaccination for 
MSM (although the scope of coverage is unknown) and no-free vaccination for 
travellers to endemic areas [8, 18]. Additionally, the official notification system 
does not register sexual orientation data in our country. Thus, the magnitude of 
sexually transmitted HAV is likely underestimated. The incorporation of detailed 
questionnaires to capture sexual history of the patients would be very useful to 
establish epidemiological links between cases. In this sense, some limitations of 
our study were: a)- the relatively low number of samples analysed, together with 
the low number of variables provided by the epidemiological records, which did 
not allow statistical analyses to compare course of infection, time of 
hospitalization, morbidity of infection, comorbidities, among HIV(+) vs HIV(-) 
MSM patients, b)- the impossibility of amplify the RNA genome in all IgM (+) 
samples, probably due to a bad sample conservation for molecular assays, or 
low viral load by the time of sampling. 
Molecular characterization helped to confirm the outbreak and demonstrated 
that laboratory results, when combined with reliable epidemiologic data, can be 
effective in understanding transmission networks. Although all MSM-related 
sequences grouped with sequences from EU outbreaks suggesting imported 
cases, none of the patients had reported travelling to Europe during the 
AC
CE
PT
ED
 M
AN
US
CR
IPT
 6 
 
incubation period, so establishing the infection link is very difficult. However, this 
does not rule out that some MSM traveller with subclinical HA or a case not 
officially notified may have been the link between the outbreaks. 
During this study, 4 cases of HA not associated to MSM were reported; their 
sequences were phylogenetically distinct from the MSM sequences. Two cases 
were non-vaccinated adult women, who travelled to high endemic areas in 
South America. The lack of immunization in adults makes these patients a 
reservoir for the virus (HAV-infected person can be viremic up to 6 weeks 
through their clinical course), since it is excreted in stool for up to 2 weeks prior 
to becoming symptomatic, being able to generate new cases or a new outbreak 
situation. The other 2 cases that were not related to the outbreak belonged to 
Peruvian unvaccinated children, living in an area 86km away from the city of 
Córdoba. The immigration of individuals without vaccination coverage is a 
matter to be addressed when trying to control HAV in our region.  
Many questions arise from this study: why three strains of HAV caused 
outbreaks in MSM around the world? Where did the outbreak originate? Which 
is the evolutionary history of the strains? How did these strains move around 
the world? Why did only one of the strains cause the outbreak of hepatitis A 
among MSM in our region? Phylodynamic studies could answer some of these 
questions, and should be made in the near future. 
The improved surveillance of HAV will detect new possible outbreaks in specific 
populations (as MSM), evaluate the impact of the post-outbreak intervention, 
and will allow to obtain a better understanding of the HAV transmission in our 
area. 
Finally, based on: (a) the recent HAV outbreaks among MSM reported 
worldwide, (b) the fact that MSM usually become infected at later ages, when 
the severity of the disease is more evident, (c) the low proportion of immune 
individuals for HAV observed among young adult individuals, and (d) the access 
to free hepatitis A vaccination in our country, we strongly recommend to 
improve communication strategies to raise awareness among health personnel 
and the general population to increase vaccination. This will help to mitigate 
viral dissemination in our population and to prevent new outbreaks of HAV in 
MSM. 
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FIGURE 1. Hepatitis A cases occurred during the outbreak from April 2017 to 
July 2018, Argentina (n = 32). Each case is located in the week of onset of 
illness. Sex, sexual orientation, HIV-coinfection and travel history is indicated.  
 
 
 
FIGURE 2. Phylogenetic analysis (Maximum Likelihood) of the VP1/2A genomic 
region (360nt) of viral strains from hepatitis A cases in Argentina, 2017- 2018. 
Red circles: sequences from MSM outbreak from Argentina 2017-2018. Yellow 
circles: other Argentinean sequences from the same period of the outbreak, of 
probable endemic circulation. Blue diamonds: European outbreak strains. 
Samples CbaARG_10, 11, 13 and 16 are from HIV+ patients.    
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Table 1. Characteristics of notified acute hepatitis A cases in Cordoba, Argentina. 
July 2017-April 2018 
 
 
 
Characteristics 
 
Total 
(n=32)a 
Demographic Characteristics  
Age, median (range) of adults patientsb 31.9 (21-55) 
Male patients, number 28 
Female, number 4 
Clinical -epidemiological characteristics and risk factors  
MSM/men, ratio 16/23 
Travel abroad 2 months before symptom onset, numberc 3 
Contact with infected individuals, number d 3 
Severe hepatic failuree 6 
Sexually transmitted co-infectionsf  
HIV, number 8 
HBV, number 1 
HCV, number 0 
Vaccination  
Patients vaccinated, numberg 1 
 
 
 
HBV: hepatitis B virus; HCV: hepatitis C virus; HIV: human immunodeficiency virus, MSM: men who 
have sex with men; NA: not applicable. 
a Sexual orientation recorded among 27 patients. 
b Two patients were unvaccinated Peruvian children (one male five years and one female six years 
old) inhabitants of a small town 86Km away from the city of Cordoba.  
c Three patients (two females and one male) travelled abroad, to Chile, Ecuador and Peru, 
respectively.  
d Three patients reported have had close contact with somebody with known acute hepatitis A. 
e Data available among 23 patients.  
f Information missing for some patients. 
g One MSM case that was vaccinated with one dose of a monovalent hepatitis A vaccine 15 years 
before disease onset 
 
AC
CE
PT
ED
 M
AN
US
CR
IPT
